The recent demonstration of active brown adipose tissue (BAT) in adult humans, along with the discovery of vast cellular and metabolic plasticity of adipocyte phenotypes, has given new hope of targeting adipose tissue for therapeutic benefit. Application
PBM effects on those proinflammatory cytokines can justify the reduction in the levels of the antibody [63]. Additionally, PBM immunomodulatory and inflammatory effects have proven to downregulate the inflammatory cytokines, to regulate the release of both ROS and NO and to promote the synthesis of...